Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.090
+0.110 (5.56%)
Nov 20, 2024, 4:00 PM EST - Market closed
Armata Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 76 | 117 | 45 | 148 | 56 | 32 | |
Market Cap Growth | -20.88% | 161.30% | -69.80% | 165.90% | 72.90% | - | |
Enterprise Value | 194 | 207 | 59 | 149 | 53 | 27 | |
Last Close Price | 2.09 | 3.24 | 1.24 | 5.48 | 2.98 | 3.25 | |
PS Ratio | 13.82 | 25.86 | 8.14 | 33.18 | 67.83 | - | |
PB Ratio | -1.68 | -3.65 | 1.24 | 5.84 | 2.96 | 2.21 | |
P/TBV Ratio | - | - | 1.38 | 6.78 | 3.63 | 2.91 | |
EV/Sales Ratio | 35.45 | 45.66 | 10.69 | 33.23 | 64.37 | - | |
Debt / Equity Ratio | -2.65 | -3.75 | 1.35 | 1.50 | 0.70 | 0.20 | |
Asset Turnover | 0.05 | 0.05 | 0.07 | 0.08 | 0.03 | - | |
Quick Ratio | 0.16 | 1.03 | 0.94 | 2.76 | 1.52 | 1.24 | |
Current Ratio | 0.19 | 1.16 | 1.09 | 3.11 | 1.62 | 1.36 | |
Return on Equity (ROE) | - | -3439.35% | -120.10% | -104.65% | -132.62% | -174.80% | |
Return on Assets (ROA) | -24.57% | -26.32% | -27.89% | -27.25% | -41.53% | -56.22% | |
Return on Capital (ROIC) | -27.93% | -29.51% | -31.15% | -31.22% | -54.55% | -89.41% | |
Earnings Yield | -54.70% | -58.95% | -82.37% | -15.60% | -39.73% | -60.33% | |
FCF Yield | -55.65% | -47.45% | -77.40% | -16.76% | -34.20% | -48.96% | |
Buyback Yield / Dilution | -0.21% | -5.19% | -42.27% | -46.84% | -104.93% | -72.15% | |
Total Shareholder Return | -0.21% | -5.19% | -42.27% | -46.84% | -104.93% | -72.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.